Tag Archives: Zantac

GSK recalls popular heartburn medicine Zantac: U.K. medicines watchdog

FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera (Reuters) – GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a “precautionary measure” due to a probable cancer-causing impurity in the drug, Britain’s medicines watchdog said on Tuesday. The move follows the U.S.… Read More »

Zantac and some OTC meds found to contain suspected carcinogen first discovered in blood pressure drugs

The saga of potentially dangerous impurities in the U.S. drug supply continues. A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Sanofi’s Zantac and some over-the-counter heartburn drugs.  At this point, the FDA says that while N-nitrosodimethylamine (NDMA) has been discovered in these ranitidine medicines like… Read More »